Clinical Trials Directory

Trials / Completed

CompletedNCT02056743

Clinical Trials on Evaluate the Red Ginseng and Fermented-Red Ginseng Affect to Drug Metabolizing Enzyme and Transporter in Healthy Volunteers

Clinical Trials on Evaluate the Red Ginseng and Fermented-Red Ginseng Affect to Drug Metabolizing Enzyme and Transporter in Healthy Volunteers; Open-label, Parallel Group

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Chonbuk National University Hospital · Academic / Other
Sex
Male
Age
20 Years – 55 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate the possibility of drug interactions before and after taking red ginseng or fermented-red ginseng by estimating metabolic rate of indicator drugs for cytochrome P450 and P-glycoprotein.

Conditions

Interventions

TypeNameDescription
DRUGCYP cocktailEach group administered CYP cocktail (Caffeine 200mg + Losartan 50mg + Omeprazole 20mg + Dextromethorphan 30mg + Midazolam 7.5mg) under fasting conditions.
DRUGFexofenadine 30mgEach group administered Fexofenadine 30mg under fasting conditions.
DIETARY_SUPPLEMENTRed ginsengDuring 4\~17th days, end of the period 1, the group of red ginseng administered red ginseng extract.
DIETARY_SUPPLEMENTFermented-red ginsengDuring 4\~17th days, end of the period 1, the group of fermented-red ginseng administered fermented-red ginseng extract.

Timeline

Start date
2013-09-01
Primary completion
2013-10-01
First posted
2014-02-06
Last updated
2014-02-06

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02056743. Inclusion in this directory is not an endorsement.